|
Mr. Thomas joined Critical Therapeutics as Chief Financial Officer in April 2004 and has served as President since June 2006 and Chief Executive Officer since December 2006. He served as Treasurer from May 2004 to June 2006 and as Senior Vice President of Finance from December 2004 to June 2006. From March 2000 to April 2004, he was employed by Esperion Therapeutics, Inc., a biopharmaceutical company focused on therapies to improve the treatment of cardiovascular disease, which was acquired by Pfizer Inc. in February 2004. Mr. Thomas served in a variety of finance positions with Esperion, including most recently as Chief Financial Officer. From September 1997 to March 2000, Mr. Thomas served as Director of Finance and Corporate Controller for Mechanical Dynamics, Inc., a publicly-held software company. Prior to that, Mr. Thomas was a manager with Arthur Andersen LLP where he was a certified public accountant. He received a B.B.A. from the University of Michigan. | 